Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Section I. Basic Genetic Concepts
1. Clinical approach to the patient with neurogenetic disease
2. Genetic and genomic testing for neurological disease in clinical practice
Brent L. Fogel and Daniel Geschwind
3. Ethical issues in neurogenetics
Wendy R. Uhlmann
4. Evolving views of human genetic variation and its relationship to neurologic and psychiatric disease
5. Epigenetic mechanisms underlying nervous system diseases
Mark F. Mehler and Irfan Qureshi
Jeffrey R. Bishop
7. Bioinformatics and genomic databases
Giovanni Coppola and Jason Chen
8. Towards precision medicine
Section II. Recurring Biological Themes in Neurogenetics
9. Repeat expansion diseases
Henry Lauris Paulson
10. Mitochondrial diseases
11. The CAG – polyglutamine repeat diseases: A clinical, molecular, genetic and pathophysiological nosology
Albert R. La Spada
Section III. Movement Disorders
12. Autosomal dominant cerebellar ataxias
13. Autosomal recessive cerebellar ataxias
Brent L. Fogel
14. Genetics of Parkinson disease
Aloysius Domingo and Christine Klein
15. Essential Tremor
Elan Louis and Lorraine Clark
16. Inherited dystonias: Clinical features and molecular pathways
Corinne Elise Weisheit, Samuel S. Pappas and William Dauer
17. Huntington’s Disease
Sarah Tabrizi, Rhia Ghosh and Amanda Dolphin
18. Wilson Disease and related copper disorders
19. Neurodegeneration with brain iron accumulation (NBIA)
Susan Judith Hayflick and Penny Hogarth
20. Primary familial brain calcifications
Section IV. Neurodevelopmental Disorders
21. Genetics of autism spectrum disorder
22. The emerging genetic landscape of cerebral palsy
Clare Louise van Eyk, Mark Corbett and Alastair MacLennan
23. Tourette disorder and other tic disorders
Thomas Fernandez, Matthew William State and Christopher Pittenger
24. Sex chromosome aneuploidies
David Skuse, Frida Printzlau and Jeanne Wolstencroft
25. Fragile X syndrome and fragile X-associated tremor ataxia syndrome
Deborah Ann Hall
Genetic methodologies are having a significant impact on the study of neurological and psychiatric disorders. Using genetic science, researchers have identified over 200 genes that cause or contribute to neurological disorders. Still an evolving field of study, defining the relationship between genes and neurological and psychiatric disorders is evolving rapidly and expected to grow in scope as more disorders are linked to specific genetic markers. Part I covers basic genetic concepts and recurring biological themes, and begins the discussion of movement disorders and neurodevelopmental disorders, leading the way for Part II to cover a combination of neurological, neuromuscular, cerebrovascular, and psychiatric disorders. This volume in the Handbook of Clinical Neurology will provide a comprehensive introduction and reference on neurogenetics for the clinical practitioner and the research neurologist.
- Presents a comprehensive coverage of neurogenetics
- Details the latest science and impact on our understanding of neurological psychiatric disorders
- Provides a focused reference for clinical practitioners and the neuroscience/neurogenetics research community
Neuroscience researchers, clinical neurologists, clinical psychologists, and genetics researchers
- No. of pages:
- © Elsevier 2018
- 26th January 2018
- Hardcover ISBN:
- eBook ISBN:
Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at UCLA. In his capacity as Senior Associate Dean and Associate Vice Chancellor of Precision Health, he leads the Institute for Precision Health at UCLA. His laboratory has pioneered the application of systems biology methods in neurologic and psychiatric disease, describing multiple disease-causing genes and disease mechanisms in the book “Neurodevelopmental and Neurodegenerative Diseases.” Dr. Geschwind has put considerable effort into fostering large-scale collaborative patient resources for genetic research and data sharing in autism research. He has served on numerous scientific advisory boards, including the Faculty of 1000 Medicine, the Executive Committee of the American Neurological Association, the Scientific Advisory Board for the Allen Institute for Brain Science, the NIMH Advisory Council and the NIH Council of Councils. He has published over 400 papers and serves on the editorial boards of Cell, Neuron and Science. He has received several awards for his laboratory’s work and leadership including the Ruane Prize from the Brain and Behavior Foundation in 2013 and the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association (ANA) in 2004. He is an elected Member of the American Association of Physicians and the National Academy of Medicine.
Los Angeles, CA, USA
Dr. Henry Paulson is the Lucile Groff Professor of Neurology for Alzheimer’s Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, where he directs the programs in neurodegenerative diseases, the Michigan Alzheimer’s Disease Center and co-directs the University of Michigan Protein Folding Diseases Initiative. Dr. Paulson received his MD and PhD from Yale University in 1990, then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. From 1997 to 2007, he was on the Neurology faculty at the University of Iowa. Dr. Paulson’s research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with a focus on hereditary ataxias, polyglutamine diseases, and frontotemporal dementia. Dr. Paulson serves on the scientific advisory boards of numerous disease-related national organizations, and is past-Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.
Lucile Groff Professor of Neurology for Alzheimer’s Disease and Related Disorders, Department of Neurology, University of Michigan Health System, Ann Arbor, MI, USA
Dr. Christine Klein is a Professor of Neurology and Neurogenetics. She studied medicine in Hamburg, Heidelberg, Luebeck (1988-1994), and London (with Dr. N.P. Quinn in 1994/1995). She moved to Boston from 1997-1999 for a fellowship in Molecular Neurogenetics under the mentorship of Dr. X.O. Breakefield. Dr. Klein completed her neurology training at Luebeck University with Dr. D. Koempf in 2004, followed by a series of summer sabbaticals in movement disorders with Dr. A.E. Lang in Toronto, Canada in 2004-2015. She was appointed Lichtenberg Professor at the Department of Neurology of Luebeck University in 2005, where her research has focused on the clinical and molecular genetics of movement disorders and its functional consequences. In 2009, Dr. Klein has been awarded a Schilling Section of Clinical and Molecular Neurogenetics at the University of Luebeck and has become Director of the newly founded Institute of Neurogenetics in 2013. Dr. Klein has published over 400 scientific papers and is the 2008 recipient of the Derek Denny-Brown Award of the American Neurological Association. She is an Associate Editor of ‘Annals of Neurology’ and of ‘Movement Disorders’. She has served as chair of the Congress Scientific Program Committee of the 2016/2017 Annual Congresses of the International Parkinson and Movement Disorder Society and is President-Elect of the German Neurological Society.
Schilling Professor of Neurogenetics, Director of the Institute of Neurogenetics, University of Lübeck, Lübeck, Germany
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.